Literature DB >> 19960087

The importance of FDA approval packages and briefing documents in pharmacy education.

Larry D Sasich, Sana R Sukkari, G Elliott Cook, Donald A Tuttle.   

Abstract

Mesh:

Year:  2009        PMID: 19960087      PMCID: PMC2779639     

Source DB:  PubMed          Journal:  Am J Pharm Educ        ISSN: 0002-9459            Impact factor:   2.047


× No keyword cloud information.
  5 in total

1.  Accessing FDA approval packages and briefing documents.

Authors:  Joseph Ohmer; Jeffrey W Miller; Larry D Sasich
Journal:  Ann Pharmacother       Date:  2007-10-30       Impact factor: 3.154

2.  The need for improved access to FDA reviews.

Authors:  Alec B O'Connor
Journal:  JAMA       Date:  2009-07-08       Impact factor: 56.272

3.  Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus.

Authors:  Steven E Nissen; Kathy Wolski; Eric J Topol
Journal:  JAMA       Date:  2005-10-20       Impact factor: 56.272

4.  Selective publication of antidepressant trials and its influence on apparent efficacy.

Authors:  Erick H Turner; Annette M Matthews; Eftihia Linardatos; Robert A Tell; Robert Rosenthal
Journal:  N Engl J Med       Date:  2008-01-17       Impact factor: 91.245

5.  Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation.

Authors:  Kristin Rising; Peter Bacchetti; Lisa Bero
Journal:  PLoS Med       Date:  2008-11-25       Impact factor: 11.069

  5 in total
  1 in total

1.  Beyond PubMed: Searching the "Grey Literature" for Clinical Trial Results.

Authors:  Leslie Citrome
Journal:  Innov Clin Neurosci       Date:  2014-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.